Skip to main content

Past Fellow Publications

Antiviral potential of nanoparticles for the treatment of Coronavirus infections.
Sarkar J, Das S, Aich S, Bhattacharyya P, Acharya K.J Trace Elem Med Biol. 2022 Jul;72:126977. doi: 10.1016/j.jtemb.2022.126977. Epub 2022 Mar 26.PMID: 35397331 

Comparative review on left-handed Z-DNA.
Roy R, Chakraborty P, Chatterjee A, Sarkar J.Front Biosci (Landmark Ed). 2021 Apr 30;26(5):29-35. doi: 10.52586/4922.PMID: 34027648 

Bilateral adrenal hemorrhage after pancreaticoduodenectomy.
Andres S, Suchak N, Brady M, Kukar M, Sarkar J.J Surg Case Rep. 2023 Jul 31;2023(7):rjad411. doi: 10.1093/jscr/rjad411. eCollection 2023 Jul.PMID: 37528912

Tuberculosis and COVID-19: A combined global threat to human civilization.
Patra K, Batabyal S, Mandal K, Ghose D, Sarkar J.Clin Epidemiol Glob Health. 2022 May-Jun;15:101031. doi: 10.1016/j.cegh.2022.101031. Epub 2022 Mar 27.PMID: 35372717

A Review on the Production Methods and Applications of Graphene-Based Materials.
Al Faruque MA, Syduzzaman M, Sarkar J, Bilisik K, Naebe M.Nanomaterials (Basel). 2021 Sep 16;11(9):2414. doi: 10.3390/nano11092414.PMID: 34578730 

Drug-induced diabetes and hepatoxicity in COVID-19 patients.
Ghosh R, Basak U, Ghosh D, Sarkar J.Diabetes Metab Syndr. 2022 Jun;16(6):102514. doi: 10.1016/j.dsx.2022.102514. Epub 2022 May 22.PMID: 35649305 

Mucormycosis: A new threat to Coronavirus disease 2019 with special emphasis on India.
Ghosh D, Dey S, Chakraborty H, Mukherjee S, Halder A, Sarkar A, Chakraborty P, Ghosh R, Sarkar J.Clin Epidemiol Glob Health. 2022 May-Jun;15:101013. doi: 10.1016/j.cegh.2022.101013. Epub 2022 Mar 19.PMID: 35342843 

Role of vasopressin in maintenance of potassium homeostasis in severe hemorrhage.
Uyehara CF, Sarkar J.Am J Physiol Regul Integr Comp Physiol. 2013 Jul 15;305(2):R101-3. doi: 10.1152/ajpregu.00206.2013. Epub 2013 May 15.PMID: 23678030

I-Health: SDN-Based Fog Architecture for IIoT Applications in Healthcare.
Sarkar JL, V R, Majumder A, Pati B, Panigrahi CR, Wang W, Qureshi NMF, Su C, Dev K.IEEE/ACM Trans Comput Biol Bioinform. 2022 Jul 26;PP. doi: 10.1109/TCBB.2022.3193918. Online ahead of print.PMID: 35881600

ASO Author Reflections: How Does Cholestasis Worsen Pancreatic Cancer Progression?
Sarkar J, Takabe K.Ann Surg Oncol. 2023 Mar;30(3):1642-1643. doi: 10.1245/s10434-022-12946-7. Epub 2022 Dec 18.PMID: 36529779 

Fluctuations in Gut Microbiome Composition During Immune Checkpoint Inhibitor Therapy.
Sarkar J, Cortes Gomez E, Oba T, Chen H, Dy GK, Segal BH, Ernstoff MS, Ito F.World J Oncol. 2023 Jun;14(3):178-187. doi: 10.14740/wjon1587. Epub 2023 Jun 11.PMID: 37350807 

Tertiary Lymphoid Structures as Mediators of Immunotherapy Response.
Vaghjiani RG, Skitzki JJ.Cancers (Basel). 2022 Aug 1;14(15):3748. doi: 10.3390/cancers14153748.PMID: 35954412 

Analysis of Early Lower Extremity Re-amputation.
Zambetti BR, Stiles ZE, Gupta PK, Stickley SM, Brahmbhatt R, Rohrer MJ, Kempe K.Ann Vasc Surg. 2022 Apr;81:351-357. doi: 10.1016/j.avsg.2021.10.030. Epub 2021 Nov 12.PMID: 34780940

Plastic Surgery Reconstruction of Sarcoma Resection Defects: Form and Function.
Stiles ZE, Lohman RF, Mann GN.Surg Clin North Am. 2022 Aug;102(4):583-599. doi: 10.1016/j.suc.2022.04.008. Epub 2022 Jun 24.PMID: 35952689

Massive intraperitoneal lipoleiomyoma with extension into the rectus sheath.
Stiles ZE, Caulkins M, Zsiros E, Mann GN.ANZ J Surg. 2022 Nov;92(11):3088-3090. doi: 10.1111/ans.17551. Epub 2022 Feb 18.PMID: 35178845 

Lymph Node Metastases in Gastrointestinal Stromal Tumors: an Uncommon Event.
Stiles ZE, Fleming AM, Dickson PV, Tsao M, Glazer ES, Shibata D, Deneve JL.Ann Surg Oncol. 2022 Dec;29(13):8641-8648. doi: 10.1245/s10434-022-12582-1. Epub 2022 Oct 5.PMID: 36197560

ASO Visual Abstract: Lymph Node Metastases in Gastrointestinal Stromal Tumors-An Uncommon Event.
Stiles ZE, Fleming AM, Dickson PV, Tsao M, Glazer ES, Shibata D, Deneve JL.Ann Surg Oncol. 2022 Dec;29(13):8651-8652. doi: 10.1245/s10434-022-12630-w.PMID: 36180618

ASO Author Reflections: Nodal Disease Burden in Patients with Gastrointestinal Stromal Tumor.
Fleming AM, Stiles ZE, Deneve JL.Ann Surg Oncol. 2022 Dec;29(13):8649-8650. doi: 10.1245/s10434-022-12591-0. Epub 2022 Oct 2.PMID: 36183019

Gracilis Flap Reconstruction After Proctocolectomy for Malignancy and Inflammatory Bowel Disease.
DeLozier OM, Stiles ZE, Shibata D, Deneve JL, Monroe J, Dickson PV, Mathew A, Chandler RG, Behrman SW.Am Surg. 2023 Feb;89(2):247-254. doi: 10.1177/00031348211011146. Epub 2021 Apr 22.PMID: 33886373

Relevance of Subcarinal Lymph Node Dissection for Gastroesophageal Junction Adenocarcinoma.
Stiles ZE, Brady M, Hochwald SN, Kukar M.J Surg Res. 2023 Oct;290:2-8. doi: 10.1016/j.jss.2023.03.047. Epub 2023 May 6.PMID: 37156029

Survival Benefit Associated With the Use of Extracorporeal Life Support for Neonates With Congenital Diaphragmatic Hernia.
Jancelewicz T, Langham MR Jr, Brindle ME, Stiles ZE, Lally PA, Dong L, Wan JY, Guner YS, Harting MT.Ann Surg. 2022 Jan 1;275(1):e256-e263. doi: 10.1097/SLA.0000000000003928.PMID: 33060376

Nationwide analysis of unplanned conversion during minimally invasive distal pancreatectomy for pancreatic adenocarcinoma.
Stiles ZE, Tolley EA, Dickson PV, Deneve JL, Kocak M, Behrman SW.HPB (Oxford). 2023 Dec;25(12):1566-1572. doi: 10.1016/j.hpb.2023.08.009. Epub 2023 Aug 22.PMID: 37652810

Lymph node metastases in young patients with gastrointestinal stromal tumor: A nationwide analysis.
Fleming AM, Herb J, Stiles ZE, Burkbauer L, Dickson PV, Glazer ES, Shibata D, Murphy AJ, Davidoff AM, Gleeson E, Kim HJ, Meyers MO, Stitzenberg K, Ollila DW, Deneve JL.J Surg Oncol. 2023 Dec;128(8):1268-1277. doi: 10.1002/jso.27431. Epub 2023 Aug 31.PMID: 37650827

Casting a wider NET: an unexpected finding in two patients with liver masses.
Stiles ZE, Sarkar J, Schwarz RE.ANZ J Surg. 2023 Jan;93(1-2):346-348. doi: 10.1111/ans.17745. Epub 2022 May 2.PMID: 35491977

Comment on "Chemoradiotherapy Followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systemic Review and Individual Patient Data Meta-Analysis".
Stiles ZE, Attwood KM, Kukar M.Ann Surg Open. 2023 Jan 30;4(1):e253. doi: 10.1097/AS9.0000000000000253. eCollection 2023 Mar.PMID: 37600888

Analysis of the Survival Impact of Postoperative Chemotherapy After Preoperative Chemotherapy and Resection for Gastric Cancer.
Drake JA, Stiles ZE, Tsao MW, Deneve JL, Glazer ES, Yakoub D, Grothey A, Somer BG, Dickson PV.Ann Surg Oncol. 2021 Mar;28(3):1417-1427. doi: 10.1245/s10434-020-09045-w. Epub 2020 Aug 27.PMID: 32856227

The anticancer effect of statins in obese esophageal cancer patients undergoing esophagectomy.
Abdelfatah E, Kukar M, Mukherjee S, Groman A, Yendamuri S.J Surg Oncol. 2022 Aug;126(2):268-278. doi: 10.1002/jso.26892. Epub 2022 Apr 27.PMID: 35476878

Predictive and Prognostic Implications of Circulating CX3CR1+ CD8+ T Cells in Non-Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy.
Abdelfatah E, Long MD, Kajihara R, Oba T, Yamauchi T, Chen H, Sarkar J, Attwood K, Matsuzaki J, Segal BH, Dy GK, Ito F.Cancer Res Commun. 2023 Mar 30;3(3):510-520. doi: 10.1158/2767-9764.CRC-22-0383. eCollection 2023 Mar.PMID: 37009132 

ASO Visual Abstract: High Risk, High Reward: Frailty in Colorectal Cancer Surgery Associates with Worse Postoperative Outcomes But Equivalent Long-Term Oncologic Outcomes.
Abdelfatah E, Ramos-Santillan V, Cherkassky L, Cianchetti K, Mann G.Ann Surg Oncol. 2023 Apr;30(4):2046-2047. doi: 10.1245/s10434-022-13090-y.PMID: 36745258

An immune-inflamed tumor microenvironment as defined by CD8 score is associated with favorable oncologic outcomes in hepatocellular carcinoma independent of measures of tumor mutational burden.
Cherkassky L, Oshi M, Abdelfatah E, Wu R, Takabe Y, Yan L, Endo I, Takabe K.Am J Cancer Res. 2022 Jul 15;12(7):3099-3110. eCollection 2022.PMID: 35968349 

High Risk, High Reward: Frailty in Colorectal Cancer Surgery is Associated with Worse Postoperative Outcomes but Equivalent Long-Term Oncologic Outcomes.
Abdelfatah E, Ramos-Santillan V, Cherkassky L, Cianchetti K, Mann G.Ann Surg Oncol. 2023 Apr;30(4):2035-2045. doi: 10.1245/s10434-022-12970-7. Epub 2023 Jan 17.PMID: 36648616

Urine as a Source of Liquid Biopsy for Cancer.
Oshi M, Murthy V, Takahashi H, Huyser M, Okano M, Tokumaru Y, Rashid OM, Matsuyama R, Endo I, Takabe K.Cancers (Basel). 2021 May 28;13(11):2652. doi: 10.3390/cancers13112652.PMID: 34071230

COVID-19 Pandemic and Indigenous Representation in Public Health Data.
Huyser KR, Horse AJY, Kuhlemeier AA, Huyser MR.Am J Public Health. 2021 Oct;111(S3):S208-S214. doi: 10.2105/AJPH.2021.306415.PMID: 34709868

Transoral Minimally Invasive Tracheoplasty Technique for Cervical Tracheomalacia.
Huyser MR, Tukey MH, Ely S, Lo JC, Ray AL, Ashiku SK.Ann Thorac Surg. 2021 Aug;112(2):e101-e102. doi: 10.1016/j.athoracsur.2020.11.047. Epub 2021 Jan 9.PMID: 33434546

Modern Elective Laparoscopic Cholecystectomy Carries Extremely Low Postoperative Infection Risk.
Ely S, Rothenberg KA, Beattie G, Gologorsky RC, Huyser MR, Chang CK.J Surg Res. 2020 Feb;246:506-511. doi: 10.1016/j.jss.2019.09.038. Epub 2019 Oct 31.PMID: 31679799

Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer.
Tokumaru Y, Oshi M, Huyser MR, Yan L, Fukada M, Matsuhashi N, Futamura M, Akao Y, Yoshida K, Takabe K.Sci Rep. 2021 Jul 8;11(1):14134. doi: 10.1038/s41598-021-93681-z.PMID: 34239017 

APOBEC3F expression in triple-negative breast cancer is associated with tumor microenvironment infiltration and activation of cancer immunity and improved survival.
Wu R, Oshi M, Asaoka M, Huyser MR, Tokumaru Y, Yamada A, Yan L, Endo I, Ishikawa T, Takabe K.Am J Cancer Res. 2022 Feb 15;12(2):744-762. eCollection 2022.PMID: 3526179

Abundance of Microvascular Endothelial Cells Is Associated with Response to Chemotherapy and Prognosis in Colorectal Cancer.
Oshi M, Huyser MR, Le L, Tokumaru Y, Yan L, Matsuyama R, Endo I, Takabe K.Cancers (Basel). 2021 Mar 23;13(6):1477. doi: 10.3390/cancers13061477.PMID: 33807015

A prognostic score based on long-term survivor unique transcriptomic signatures predicts patient survival in pancreatic ductal adenocarcinoma.
Katsuta E, Huyser M, Yan L, Takabe K.Am J Cancer Res. 2021 Sep 15;11(9):4294-4307. eCollection 2021.PMID: 34659888 

Outcomes following interventions to sustain body weight in esophageal cancer patients starting preoperative therapy: a retrospective cohort study.
Velotta JB, Dusendang JR, Kwak H, Huyser M, Patel A, Ashiku SK, Herrinton LJ.J Thorac Dis. 2021 Sep;13(9):5477-5486. doi: 10.21037/jtd-20-3220.PMID: 34659814

MELK expression in breast cancer is associated with infiltration of immune cell and pathological compete response (pCR) after neoadjuvant chemotherapy.
Oshi M, Gandhi S, Huyser MR, Tokumaru Y, Yan L, Yamada A, Matsuyama R, Endo I, Takabe K.Am J Cancer Res. 2021 Sep 15;11(9):4421-4437. eCollection 2021.PMID: 34659896 

Low adipocyte hepatocellular carcinoma is associated with aggressive cancer biology and with worse survival.
Mukhopadhyay S, Tokumaru Y, Oshi M, Endo I, Yoshida K, Takabe K.Am J Cancer Res. 2022 Aug 15;12(8):4028-4039. eCollection 2022.PMID: 36119828

Self-Diagnosis of Surgical Site Infections: Lessons from a tertiary care centre in Karachi, Pakistan.
Sajun SZ, Albutt K, Moosajee US, Drevin G, Mukhopadhyay S, Samad L.Pak J Med Sci. 2020 Jan;36(1):S55-S60. doi: 10.12669/pjms.36.ICON-Suppl.1716.PMID: 31933608

Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer.
Oshi M, Tokumaru Y, Mukhopadhyay S, Yan L, Matsuyama R, Endo I, Takabe K.Cells. 2021 Mar 15;10(3):653. doi: 10.3390/cells10030653.PMID: 33804148

Octogenarians' Breast Cancer Is Associated with an Unfavorable Tumor Immune Microenvironment and Worse Disease-Free Survival.
Okano M, Oshi M, Mukhopadhyay S, Qi Q, Yan L, Endo I, Ohtake T, Takabe K.Cancers (Basel). 2021 Jun 11;13(12):2933. doi: 10.3390/cancers13122933.PMID: 34208219 

Identifying essential components of surgical care delivery through quality improvement: An updated surgical assessment tool.
Lin Y, Raykar NP, Saluja S, Mukhopadhyay S, Sharma S, Frett B, Enumah S, Iverson KR, Johnson W, Meara JG, Shrime MG.Int J Surg. 2020 Oct;82:103-107. doi: 10.1016/j.ijsu.2020.08.002. Epub 2020 Aug 15.PMID: 32810595 

Wide Resection of Extremity/Truncal Soft Tissue Sarcomas.
Patel A, Kane JM 3rd.Surg Clin North Am. 2022 Aug;102(4):551-565. doi: 10.1016/j.suc.2022.05.002. Epub 2022 Jun 24.PMID: 35952687

Transforming Gait: Video-Based Spatiotemporal Gait Analysis.
Cotton RJ, McClerklin E, Cimorelli A, Patel A, Karakostas T.Annu Int Conf IEEE Eng Med Biol Soc. 2022 Jul;2022:115-120. doi: 10.1109/EMBC48229.2022.9871036.PMID: 36085602

Melanoma trials that defined surgical management: Brief overview of current/upcoming adjuvant/neoadjuvant trials.
Patel A, Skitzki J.J Surg Oncol. 2022 Jan;125(1):38-45. doi: 10.1002/jso.26746.PMID: 34897704

Organoids Are Limited in Modeling the Colon Adenoma-Carcinoma Sequence.
Tokumaru Y, Oshi M, Patel A, Tian W, Yan L, Matsuhashi N, Futamura M, Yoshida K, Takabe K.Cells. 2021 Feb 25;10(3):488. doi: 10.3390/cells10030488.PMID: 33668713 

Clinical Relevance of Estrogen Reactivity in the Breast Cancer Microenvironment.
Takeshita T, Tokumaru Y, Oshi M, Wu R, Patel A, Tian W, Hatanaka Y, Hatanaka KC, Yan L, Takabe K.Front Oncol. 2022 May 23;12:865024. doi: 10.3389/fonc.2022.865024. eCollection 2022.PMID: 35677163 

High RAD51 gene expression is associated with aggressive biology and with poor survival in breast cancer.
Wu R, Patel A, Tokumaru Y, Asaoka M, Oshi M, Yan L, Ishikawa T, Takabe K.Breast Cancer Res Treat. 2022 May;193(1):49-63. doi: 10.1007/s10549-022-06552-0. Epub 2022 Mar 6.PMID: 35249172

The Unfolded Protein Response Is Associated with Cancer Proliferation and Worse Survival in Hepatocellular Carcinoma.
Patel A, Oshi M, Yan L, Matsuyama R, Endo I, Takabe K.Cancers (Basel). 2021 Sep 3;13(17):4443. doi: 10.3390/cancers13174443.PMID: 34503253 

Enhanced immune response outperform aggressive cancer biology and is associated with better survival in triple-negative breast cancer.
Oshi M, Patel A, Wu R, Le L, Tokumaru Y, Yamada A, Yan L, Matsuyama R, Ishikawa T, Endo I, Takabe K.NPJ Breast Cancer. 2022 Aug 9;8(1):92. doi: 10.1038/s41523-022-00466-2.PMID: 35945417 

Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti-PD-L1 Therapy via IRF8 Expression.
Patel A, Oba T, Kajihara R, Yokoi T, Abrams SI, Ito F.J Immunol. 2021 Sep 1;207(5):1298-1309. doi: 10.4049/jimmunol.2100281. Epub 2021 Aug 6.PMID: 34362833 

A Novel Four-Gene Score to Predict Pathologically Complete (R0) Resection and Survival in Pancreatic Cancer.
Oshi M, Tokumaru Y, Patel A, Yan L, Matsuyama R, Endo I, Katz MHG, Takabe K.Cancers (Basel). 2020 Dec 4;12(12):3635. doi: 10.3390/cancers12123635.PMID: 33291601 

G2M checkpoint pathway alone is associated with drug response and survival among cell proliferation-related pathways in pancreatic cancer.
Oshi M, Patel A, Le L, Tokumaru Y, Yan L, Matsuyama R, Endo I, Takabe K.Am J Cancer Res. 2021 Jun 15;11(6):3070-3084. eCollection 2021.PMID: 34249445

Low expression of miR-195 is associated with cell proliferation, glycolysis and poor survival in estrogen receptor (ER)-positive but not in triple negative breast cancer.
Tokumaru Y, Oshi M, Patel A, Katsuta E, Yan L, Angarita FA, Dasgupta S, Nagahashi M, Matsuhashi N, Futamura M, Yoshida K, Takabe K.Am J Cancer Res. 2021 Jun 15;11(6):3320-3334. eCollection 2021.PMID: 34249465